Quidel Corporation (QDEL) Receives Price Target

Quidel Corporation (QDEL) : The most positive equity analysts on Quidel Corporation (QDEL) expects the shares to touch $26, whereas, the least positive believes that the stock will trade at $16 in the short term. The company is covered by 5 Wall Street Brokerage Firms. The average price target for shares are $21.2 with an expected fluctuation of $4.15 from the mean.

Quidel Corporation (QDEL) : 2 brokerage houses believe that Quidel Corporation (QDEL) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Quidel Corporation (QDEL). Zacks Investment Research suggests a Strong Buy with a rank of 1.The median of all the 7 Wall Street Analysts endorse the stock as a Buy with a rating of 2.29.


Also, Major Brokerage house, Raymond James upgrades its ratings on Quidel Corporation (NASDAQ:QDEL). According to the latest information available, the shares are now rated Outperform by the analysts at the agency. Previously, the analysts had a Market Perform rating on the shares. The rating by the firm was issued on June 13, 2016.

Quidel Corporation (NASDAQ:QDEL): The stock opened at $21.69 on Thursday but the bulls could not build on the opening and the stock topped out at $21.98 for the day. The stock traded down to $21.44 during the day, due to lack of any buying support eventually closed down at $21.74 with a loss of -0.14% for the day. The stock had closed at $21.77 on the previous day. The total traded volume was 85,924 shares.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, womens health and gastrointestinal diseases. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors, and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including infectious diseases, womens health, autoimmune diseases, bone health, thyroid diseases and fecal occult blood.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.